Title
Obesity Care Reimagined: Simulations for Real Impact
Program Description
Obesity currently affects more than 2 in 5 adults in the United States and demonstrates significant associations with cardiovascular disease, type 2 diabetes (T2D), metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH), osteoarthritis, sleep disorders, and reproductive health complications. Obesity care continues to evolve with advancing treatment options, emerging best practices in comorbidity management, and evidence-based guidance on patient-centered approaches, creating new opportunities to improve outcomes for patients living with obesity.
To support clinicians in comprehensive obesity management, this educational initiative will facilitate peer-to-peer learning, case-based discussions, and practical guidance through simulation-based scenarios. Participants will gain enhanced competence in recognizing and managing the relationships between obesity and a range of comorbidities, develop skills in creating individualized treatment plans that integrate evidence-based pharmacological and lifestyle interventions, and strengthen patient-centered communication strategies that support treatment adherence and improved patient outcomes.
Learning Objectives:
At the end of this activity, learners should be able to:
Target Audience
This activity is designed for primary care clinicians (MDs, DOs, NPs, PAs, nurses, community pharmacists) involved in the care of people with obesity.
Participation and Credit:
Learners must complete the educational content online: self-study modules, group challenges, assessment, and participate in an online live discussions. A certificate will be available to you at the end of this activity. You may print the certificate, but you cannot alter it. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Unlabeled Use Disclosure:
This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), and the curriculum clearly indicates this fact.
Support:
Supported by an unrestricted educational grant from Novo Nordisk.
Fee:
There is no charge for this activity.
Cultural/Linguistic Competency:
CAFP policy and California state law require that each learning activity have elements of cultural and linguistic proficiency included in the content. The definition of cultural and linguistic competency is the ability and readiness of health care providers and health organizations to humbly and respectfully demonstrate, effectively communicate, and tailor delivery of care to patients with diverse values, beliefs, identities, and behaviors, in order to meet patients’ social, cultural, and linguistic needs as it relates to patient health. This activity meets these requirements.
Implicit Bias:
CAFP policy and California state law require that all CME activities comprising a patient care element include either (1) examples of how implicit bias affects perceptions and treatment decisions of physicians and surgeons, leading to disparities in health outcomes and/or (2) strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics. This activity meets these requirements.
Privacy Policy:
The California Academy of Family Physicians (CAFP) is committed to protecting the privacy of its members and customers. CAFP maintains safeguards to store and secure information it has about members and customers. The safeguards may be physical, electronic or procedural. For more information, contact cafp@familydocs.org.
Questions:
For questions regarding the content of this activity or for technical assistance, contact cafp@familydocs.org.
The CAFP has made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the learner is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Any medications or treatment methods suggested in this CME activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
Copyright:
© 2024 California Academy of Family Physicians. No part of this activity may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embedded in articles or reviews.
Accreditation:
The California Academy of Family Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AAFP has reviewed Obesity Care Reimagined: Simulations for Real Impact, and deemed it acceptable for AAFP credit. Term of approval is from 09/12/2025 to 09/12/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
Faculty & disclosure:
Faculty
Ecler Jaqua, MD, MBA, FAAFP, AGSF, FACLM, DipABOM
Dr. Jaqua has no relevant financial relationships with ineligible companies.
Nicholas Pennings, DO, MFOMA, FACOFP, FAAFP
Dr. Pennings is a consultant for Abbott and an independent contractor for Medifast. These relevant financial relationships have been mitigated.
Additional Content Contributors
Kimberly Casteline, PhD
Dr. Casteline has no relevant financial relationships with ineligible companies.
Steven Haimowitz, MD
Dr. Haimowitz has no relevant financial relationships with ineligible companies.
Laurie Isenberg, MA, MILS, CHCP
Ms. Isenberg has no relevant financial relationships with ineligible companies.
Anne Jacobson
Dr. Schectel has no relevant financial relationships with ineligible companies.
Renee Wadsworth
Ms. Wadsworth has no relevant financial relationships with ineligible companies.
Conflict of Interest Statements:
The CAFP Committee on Continuing Professional Development is responsible for management and resolution of conflict for any individual who may have influence on content, who has served as faculty, or who may produce or help produce CME/CPD content for the CAFP.
Management/Resolution may include learner notification, peer review of content before presentation, changing topics, or even dismissing a potential faculty member.
It is the policy of the CAFP to ensure independence, balance, objectivity, scientific rigor, and integrity in all continuing education activities. All individuals with potential to influence the content of this program have submitted Conflict of Interest declarations that have been reviewed according to policy. Learner notification of declarations is included. All individuals with potential conflicts have been contacted by CAFP staff or CCPD members, and issues of conflict have been discussed, managed, and resolved.
